About
- About Avecho
- Board & Leadership
TPM^® Technology
Portfolio
Invest
- Investor Centre
- Media Centre
Contact

Hit enter to search or ESC to close

Phosphagenics Mylan Arbitration Hearing Concluded

November 9, 2017

Click here to read more

Post navigation

Phosphagenics Entitlement Offer Raises Over AUD3M

Phosphagenics Provides Update on TPM Propofol Development Program

Related Posts

Phosphagenics Signs Non-Binding Term Sheet for Oxymorphone Patch in Japan

January 31, 2017

CBD soft-gel product design complete

May 21, 2021May 21, 2021

Retirement of Non-Executive Director

May 28, 2018

Recent Posts

Media | Avecho featured on 9 News
June 23, 2025
New Sites Commence Recruitment For Phase III Clinical Trial
May 20, 2025
Avecho receives US$3M upfront payment from Sandoz AG
March 28, 2025

Categories

Analyst Coverage
Company Announcement
Company Report
Investor Webinar
Media Coverage
Newsletter
Press Release
Uncategorised

About us

We see a future where more patients can get even more from their treatments through innovative delivery technologies.

Stay Posted

Stay informed about our latest news and developments.

Leave this field empty if you're human:

About Avecho

TPM^® Technology

Portfolio

Investor Centre
- Investor Centre
- Media Centre

© Copyright 2019 Avecho Biotechnology Ltd.